2025 National GvHD Symposium

Friday, October 17th, 2025

The Grand Event Center / Columbus, OH

13th Annual Graft-versus-Host Disease (GvHD) Symposium

Join us for the 13th Annual GvHD Symposium, the only conference of its kind in the world focused exclusively on Graft-versus-Host Disease (GvHD)—a serious and often life-altering complication affecting over 60% of bone marrow transplant recipients.

This year's event brings together patients, caregivers, physicians, researchers, and healthcare professionals in a single, collaborative forum to learn, connect, and explore the latest advances in GvHD care and science.

Hosted by the Meredith A. Cowden Foundation in collaboration with The Ohio State University (OSU), UPMC, and the Cleveland Clinic, the symposium continues a proud tradition of driving innovation and building community in the GvHD space since 2010.

What to Expect:

Presentations from leading GvHD experts on clinical care, emerging research, and supportive strategies

A dynamic panel discussion with medical professionals and patient advocates

A welcoming environment for shared learning between providers and those with lived experience

Opportunities to network, ask questions, and engage with others facing similar challenges

Keynote Speaker:

Dr. Andy Harris, Memorial Sloan Kettering Cancer Center

Details & Registration:

Date: Friday, October 17, 2025

Location: The Grand Event Center, Columbus, OH

Cost:

Free for patients and caregivers

Standard registration for physicians, researchers, and health professionals

Registration is now open!

Why Attend?

Since 2010, the Meredith A. Cowden Foundation, alongside partners including the Case Comprehensive Cancer Center, the National Cancer Institute, and the Cleveland Clinic Taussig Cancer Institute, has brought together diverse voices to advance the understanding and treatment of GvHD.

This year’s symposium continues that mission, shining a spotlight on breakthrough research and meaningful conversations that can improve outcomes and quality of life for people living with GvHD.

We hope you’ll join us in October for this one-of-a-kind event, where science, advocacy, and community come together.

KEYNOTE SPEAKER:

Andrew Harris, MD

Memorial Sloan Kettering Cancer Center

Dr. Harris is a physician on the MSK Kids team who specializes in the use of stem cell transplantation and cellular therapies to treat children and adolescents. His patient care expertise and research focus is acute leukemia as well as graft-versus-host disease (GVHD), a potential complication of transplantation that happens when the immune system that is transferred from the donor to the transplant recipient attacks tissues in the recipient’s body.